Thrombotic predisposition associated with oral contraceptives.
D000991:Antithrombins / Q000097:blood; D001157:Arterial Occlusive Diseases / Q000139:chemically induced; D001780:Blood Coagulation Tests; D003120:Colorado; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004967:Estrogens / Q000009:adverse effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011374:Progesterone / Q000009:adverse effects; D012075:Remission, Spontaneous; D013917:Thrombin / Q000096:biosynthesis; D013924:Thrombophlebitis / Q000139:chemically induced; D013927:Thrombosis / Q000139:chemically induced*; D013997:Time Factors
D000991:Antithrombins; D003276:Contraceptives, Oral; D004967:Estrogens; D011374:Progesterone; D013917:Thrombin